In the present research, the APP/PS1 transgenic mouse model in vivo and Aβ25-35-induced hippocampal neuron cell model in vitro of AD had been established to investigate the effect of GLTs on the therapeutic action of AD. This evidence concerns the gene APP and Alzheimer disease.